P127 The SLE-DAS enables easy identification of SLE patients with moderate-to-severe disease activity and worse HR-QoL in the screening for SLE clinical trials: a post-hoc study in the phase 2 and 3 anifrolumab trials

Subjects

Subjects :

Immunologic diseases. Allergy
RC581-607

Details

Language :

English

ISSN :

20538790

Volume :

11

Issue :

Suppl 1

Database :

Directory of Open Access Journals

Journal :

Lupus Science and Medicine

Publication Type :

Academic Journal

Accession number :

edsdoj.12388a393f55484fbf40fbc0d58ffdf0

Document Type :

article

Full Text :

https://doi.org/10.1136/lupus-2024-el.181